Method for composition for treatment of gastric and duodenal dis

Details Method for composition for treatment of gastric and duodenal dis Method for composition for treatment of gastric and duodenal dis

1993-05-06

1996-04-23

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514926, 514927, A61K 31557

Patent

active

055103820

ABSTRACT:
The invention is related to the field of treating gastric and duodenal disorders and more specifically to the use of certain 13,14-dihydro-prostaglandin E derivatives, especially of PGE.sub.2, which are modified to contain a ring structure in the omega chain. The invention relates also to pharmaceutical compositions containing an active amount of these derivatives.

REFERENCES:
patent: 3937801 (1976-02-01), Uppmann
patent: 4820728 (1989-04-01), Collins
patent: 4833157 (1989-05-01), Kluender
patent: 5422368 (1995-06-01), Stjernschantz et al.
Pfitzner (1965); J. Am. Chem. Soc. 87, pp. 5670-5678.
Corey (1966); J. Am. Chem. Soc. 88, p. 5654.
Brown (1972); J. Am. Chem. Soc. 94, pp. 7159-7161.
Vincent et al. "Substituted 11-Deoxy-prostaglandins" Chem Abst 87(5) 39000 FrDemande 2301242 (1976).
Yankee et al. Chem Abstr 88, 62048x, (1978).
Bundy, Chem Abstr 90 168141d, (1979).
Chem Abst. 84:58751, 1975.
Chem Abst. 88:62048, 1978.
Chem Abst. 90:168141, 1979.

Affiliated with

Also associated with

Rating

Method for composition for treatment of gastric and duodenal dis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for composition for treatment of gastric and duodenal dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for composition for treatment of gastric and duodenal dis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2308830